Stay updated on Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedMajor update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.SummaryDifference4%
- Check17 days agoChange DetectedUpgrade version from v3.0.2 to v3.1.0 and add a contact/identifier (linshenpku@163.com and 86-10-88196561); remove the old version reference.SummaryDifference0.1%
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the 'Back to Top' link/button was removed. This is a minor maintenance change with no impact on core content, pricing, stock, or time slots.SummaryDifference0.2%
- Check39 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.2%
- Check46 days agoChange DetectedThe web page has updated its facility name and location details, specifically emphasizing the Beijing Municipality and the drug surufatinib, while removing several previous location references and drug information.SummaryDifference2%
- Check60 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial page.